Catalyst Funds Management’s CareDx CDNA Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2024
Q4
Sell
-5,000
Closed -$156K 488
2024
Q3
$156K Hold
5,000
0.03% 357
2024
Q2
$77.7K Sell
5,000
-1,300
-21% -$15.7K 0.02% 341
2024
Q1
$66.7K Buy
+6,300
New +$63K 0.02% 489

Other funds holding CDNA

Catalyst Funds Management's CDNA Position: Q4 2024 in Review

Catalyst Funds Management sold out of CareDx (CDNA) in Q4 2024, closing a stake of 5,000 shares — an estimated $156K sold.

Catalyst Funds Management first reported a position in CDNA in Q1 2024 and held it in 3 quarters. The position peaked at $156K in Q3 2024. 210 funds tracked by Wall St. Rank hold CDNA as of Q4 2024.

  • Catalyst Funds Management reported no remaining CareDx position as of Q4 2024 after selling out during the quarter.
  • Catalyst Funds Management sold 5,000 CareDx shares in Q4 2024, an estimated $156K.
  • Catalyst Funds Management first reported a position in CareDx in Q1 2024 and held it in 3 quarters.
  • Catalyst Funds Management's CareDx position peaked at $156K in Q3 2024.
  • 210 funds tracked by Wall St. Rank held CareDx as of Q4 2024.

Based on Catalyst Funds Management's 13F filing for Q4 2024, filed 10 Feb 2025.